Joanne Wuensch
Stock Analyst at Citi
(3.24)
# 2,506
Out of 4,604 analysts
1216
Total ratings
53.7%
Success rate
1.7%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintained: Hold | $172 → $150 | $133.26 | +12.56% | 44 | Aug 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Hold | $93 → $99 | $98.16 | +0.86% | 62 | Aug 6, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | n/a | $105.71 | - | 86 | Aug 4, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | n/a | $257.59 | - | 62 | Aug 4, 2026 | |
| WST West Pharmaceutical Services | Maintained: Buy | $412 | $351.02 | +17.37% | 1 | Aug 3, 2026 | |
| BAX Baxter International | Upgraded: Hold | $17 → $28 | $27.33 | +2.45% | 60 | Jul 31, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $70 → $61 | $47.74 | +27.78% | 77 | Jul 31, 2026 | |
| DXCM DexCom | Rated: Buy | $84 → $88 | $82.66 | +6.46% | 64 | Jul 31, 2026 | |
| GKOS Glaukos | Maintained: Buy | $175 → $188 | $170.93 | +9.99% | 44 | Jul 30, 2026 | |
| GEHC GE HealthCare Technologies | Rated: Hold | $69 → $75 | $70.24 | +6.78% | 26 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $375.20 | - | 35 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 | $85.99 | +27.92% | 82 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $385 | $337.03 | +14.23% | 58 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.56 | - | 5 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $69 → $76 | $74.84 | +1.55% | 55 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 → $110 | $88.97 | +23.64% | 80 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $92 → $96 | $125.00 | -23.20% | 19 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $70 → $79 | $83.60 | -5.50% | 27 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $19 | $17.68 | +7.47% | 29 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 | $19.59 | -13.22% | 44 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $350 | $323.21 | +8.29% | 43 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $124.50 | +26.10% | 57 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5.15 → $6 | $5.55 | +8.11% | 27 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $21 | $16.76 | +25.30% | 17 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $198 | $170.66 | +16.02% | 38 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $76 → $92 | $91.25 | +0.82% | 21 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.15 | $1.98 | n/a | 17 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 54.19 → CHF 55.81 | CHF 56.86 | n/a | 11 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $124 → $120 | $224.03 | n/a | 23 | Jan 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $25.81 | n/a | 2 | Sep 26, 2016 |
Insulet
Aug 6, 2026
Maintained: Hold
Price Target: $172 → $150
Current: $133.26
Upside: +12.56%
Zimmer Biomet Holdings
Aug 6, 2026
Maintained: Hold
Price Target: $93 → $99
Current: $98.16
Upside: +0.86%
Abbott Laboratories
Aug 4, 2026
Maintained: Buy
Price Target: n/a
Current: $105.71
Upside: -
Johnson & Johnson
Aug 4, 2026
Maintained: Buy
Price Target: n/a
Current: $257.59
Upside: -
West Pharmaceutical Services
Aug 3, 2026
Maintained: Buy
Price Target: $412
Current: $351.02
Upside: +17.37%
Baxter International
Jul 31, 2026
Upgraded: Hold
Price Target: $17 → $28
Current: $27.33
Upside: +2.45%
Boston Scientific
Jul 31, 2026
Maintained: Buy
Price Target: $70 → $61
Current: $47.74
Upside: +27.78%
DexCom
Jul 31, 2026
Rated: Buy
Price Target: $84 → $88
Current: $82.66
Upside: +6.46%
Glaukos
Jul 30, 2026
Maintained: Buy
Price Target: $175 → $188
Current: $170.93
Upside: +9.99%
GE HealthCare Technologies
Jul 29, 2026
Rated: Hold
Price Target: $69 → $75
Current: $70.24
Upside: +6.78%
Jul 24, 2026
Maintained: Buy
Price Target: n/a
Current: $375.20
Upside: -
Jul 22, 2026
Maintained: Buy
Price Target: $110
Current: $85.99
Upside: +27.92%
Jul 22, 2026
Maintained: Buy
Price Target: $385
Current: $337.03
Upside: +14.23%
Jul 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.56
Upside: -
Jul 8, 2026
Maintained: Hold
Price Target: $69 → $76
Current: $74.84
Upside: +1.55%
Jul 8, 2026
Maintained: Buy
Price Target: $101 → $110
Current: $88.97
Upside: +23.64%
Jul 8, 2026
Maintained: Hold
Price Target: $92 → $96
Current: $125.00
Upside: -23.20%
Jul 8, 2026
Maintained: Hold
Price Target: $70 → $79
Current: $83.60
Upside: -5.50%
Jul 8, 2026
Maintained: Hold
Price Target: $16 → $19
Current: $17.68
Upside: +7.47%
Jul 8, 2026
Maintained: Hold
Price Target: $17
Current: $19.59
Upside: -13.22%
Jul 8, 2026
Maintained: Hold
Price Target: $350
Current: $323.21
Upside: +8.29%
Jul 8, 2026
Reiterated: Buy
Price Target: $157
Current: $124.50
Upside: +26.10%
Jul 8, 2026
Maintained: Hold
Price Target: $5.15 → $6
Current: $5.55
Upside: +8.11%
Jul 8, 2026
Maintained: Buy
Price Target: $19 → $21
Current: $16.76
Upside: +25.30%
Jul 6, 2026
Reiterated: Buy
Price Target: $198
Current: $170.66
Upside: +16.02%
Jul 6, 2026
Rated: Hold
Price Target: $76 → $92
Current: $91.25
Upside: +0.82%
May 23, 2025
Maintained: Hold
Price Target: $4.15
Current: $1.98
Upside: n/a
Nov 16, 2022
Maintained: Hold
Price Target: CHF 54.19 → CHF 55.81
Current: CHF 56.86
Upside: n/a
Jan 27, 2019
Reiterated: Buy
Price Target: $124 → $120
Current: $224.03
Upside: n/a
Sep 26, 2016
Reiterated: Buy
Price Target: $40
Current: $25.81
Upside: n/a